Asensus Surgical, Inc. Stock price

Equities

ASXC

US04367G1031

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:31:06 2024-03-28 pm EDT 5-day change 1st Jan Change
0.233 USD -0.43% Intraday chart for Asensus Surgical, Inc. -17.18% -27.28%
Sales 2024 * 12.3M Sales 2025 * 22.21M Capitalization 63.64M
Net income 2024 * -62M Net income 2025 * -55M EV / Sales 2024 * 5.18 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.87 x
P/E ratio 2024 *
-1.26 x
P/E ratio 2025 *
-1.61 x
Employees 208
Yield 2024 *
-
Yield 2025 *
-
Free-Float 98.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.74%
1 week-18.75%
Current month-22.00%
1 month-23.28%
3 months-33.97%
6 months-17.78%
Current year-26.62%
More quotes
1 week
0.21
Extreme 0.2114
0.27
1 month
0.21
Extreme 0.2114
0.31
Current year
0.21
Extreme 0.2114
0.38
1 year
0.20
Extreme 0.204
0.86
3 years
0.20
Extreme 0.204
3.75
5 years
0.20
Extreme 0.204
33.22
10 years
0.20
Extreme 0.204
182.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 15-07-31
Director of Finance/CFO 57 20-08-23
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 04-12-31
Director/Board Member 59 21-07-21
Founder 70 06-07-11
More insiders
Date Price Change Volume
24-03-28 0.2333 -0.30% 679 598
24-03-27 0.234 +1.74% 1,134,033
24-03-26 0.23 -4.56% 1,612,959
24-03-25 0.241 +0.37% 4,604,515
24-03-22 0.2401 -14.25% 3,750,512

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Asensus Surgical, Inc. is a medical device company. The Company is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The Company is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.234 USD
Average target price
2 USD
Spread / Average Target
+754.70%
Consensus
  1. Stock
  2. Equities
  3. Stock Asensus Surgical, Inc. - Nyse